Press release
Pancreatic Cancer Therapeutics Market - Epidemiology Analysis, Therapy, Development and Demand Forecast to 2023
Explore Report at: www.psmarketresearch.com/market-analysis/pancreatic-cancer-therapeutics-market
Cancer instigates uncountable growth of cells due to some abnormalities in the body. Some of the common symptoms of pancreatic cancer include weight loss, diarrhea, jaundice and abdominal pain. Cancer hampers the pancreas’ normal functioning, with smoking being the major risk factor for pancreatic cancer. Diagnosis of this type of cancer is done by patient history check and complete physical examination, followed by urine, stool and blood tests. Also, personal or family history of pancreatitis and BRCA2 mutation inclines a person to be affected by pancreatic cancer.
A number of imaging techniques such as MRI, ultrasound and CT scan are used for the disease diagnosis. The most common form of treatment is chemotherapy done by medical practitioners and oncologists. The drugs approved for the pancreatic cancer treatment include, but are not limited to ONIVYDE (irinotecan liposome injection); 5-FU (fluorouracil); Gemzar (gemcitabine); and ABRAXANE (albumin-bound paclitaxel). Apart from this, FOLFIRINOX, a combination of three chemotherapy drugs (5-FU/leucovorin, irinotecan, and oxaliplatin) is commonly used in the treatment of metastatic pancreatic adenocarcinoma. Other emerging treatments involve chemotherapies for advanced pancreatic cancer, combined with agents already approved for use, which are being investigated in clinical trials.
Request for Table of Content at: www.psmarketresearch.com/market-analysis/pancreatic-cancer-therapeutics-market/toc-sample
The investment in both segments of pancreatic cancers is significant. However, the growing prevalence and growing reach of novel techniques in the developing regions are the aspects likely to drive the growth of the exocrine category, throughout the forecast period.
Presently, the global pancreatic cancer therapeutics industry is merged in nature, with only a few top companies seizing the major share of the market. Some of the top companies operating in this market are Celgene Corporation; Eli Lilly and Company; Amgen, Inc.; F. Hoffmann-La Roche AG; PharmaCyte Biotech, Inc.; Novartis AG; Teva Pharmaceutical Industries Ltd.; Clovis Oncology; Pfizer, Inc.; and Merck & Co., Inc.
Browse Other Related report at: www.psmarketresearch.com/industry-report/pharmaceuticals
Several companies are concentrating on the introduction of technologically advanced products, in order to obtain a significant share in the fast-growing medical devices area. Also, collaborations, mergers and partnerships with well-established players are the key approaches followed by top players to increase their market share, during the forecast period.
About P&S Market Research
P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.
As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.
Contact:
Abhishek
Executive – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: www.psmarketresearch.com
347, 5th Ave. #1402
New York City, NY - 10016
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pancreatic Cancer Therapeutics Market - Epidemiology Analysis, Therapy, Development and Demand Forecast to 2023 here
News-ID: 490565 • Views: …
More Releases from P&S Market Research- Pharmaceuticals
Benign Prostatic Hyperplasia Therapeutics Market - Epidemiology Analysis, Therap …
The global benign prostatic hyperplasia therapeutics market is expected to witness significant growth, as increased number of effective treatments are available for cancer. Increasing awareness regarding various cancer treatment drugs, technological advancements, and growing demand for safe and effective medications are acting as the major growth drivers for the benign prostatic hyperplasia therapeutics market. Globally, regulatory bodies are adding to the growth of the market with provision of funding, grants…
Global Esophageal Cancer Therapeutics Market Analysis, Development and Demand Fo …
Global esophageal cancer therapeutics market is expected to witness significant growth with an increasing awareness regarding cancer treatment and technological advancements. Also, high demand for safe and effective medications and rising prevalence of cancer are driving the growth of the global market. The regulatory bodies such as USFDA, EMA are supporting the growth of the global market by providing funding, designations and grants for speeding up the drug development process.
Explore…
Novel Targets for Breast Cancer Treatment Drive Estrogen Receptor-Positive (ER+) …
Estrogen Receptor-Positive (ER+) breast cancer currently exhibits a pipeline with 46 active drug candidates.
ER+ breast cancer pipeline offers novel therapeutic targets for the treatment of breast cancer
The study analyzed that the estrogen receptor positive breast cancer pipeline comprises approximately 74 drug candidates, of which nine products are in Phase III, 16 products in Phase II, 18 products in Phase I, and three products are in Pre-Clinical stage. The development of…
Serine/Threonine-Protein Kinase Inhibitors Pipeline Analysis, 2016
Serine/threonine-protein kinases (EC 2.7.11.1) are enzyme or protein that has hydroxyl (OH) group in the side chain. Phosphorylation in serine or threonine residues may cause changes in the function of the target protein. Those drugs/ligands that inhibit phosphorylating activity of these kinases are called serine/threonine protein kinases inhibitors. Serine/threonine kinase receptors are a family of transmembrane receptors containing intracellular serine/threonine kinase domains that respond to a few cytokines including the…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
